Nurix Therapeutics (NRIX) EPS (Diluted) Growth (1y) (2021 - 2026)
Nurix Therapeutics (NRIX) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,091.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -55.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -55.55% |
| Feb 28, 2026 | -18.48% |
| Nov 30, 2025 | -3.47% |
| Aug 31, 2025 | -52.66% |
| May 31, 2025 | 27.44% |
| Feb 28, 2025 | 10.82% |
| Nov 30, 2024 | -12.97% |
| Aug 31, 2024 | 1.07% |
| May 31, 2024 | -59.61% |
| Feb 29, 2024 | -0.30% |
| Nov 30, 2023 | 19.66% |
| Aug 31, 2023 | 24.33% |
| May 31, 2023 | 55.75% |
| Feb 28, 2023 | 20.78% |
| Nov 30, 2022 | -9.39% |
| Aug 31, 2022 | -38.17% |
| May 31, 2022 | -68.14% |
| Feb 28, 2022 | 33.60% |
| Nov 30, 2021 | 25.36% |
| Aug 31, 2021 | 40.51% |